Literature DB >> 6793580

Evidence that the platelet plasma membrane is impermeable to calcium and magnesium complexes of A23187. A23187-induced secretion is inhibited by MG2+ and Ca2+, and requires aggregation and active cyclooxygenase.

H Holmsen, C A Dangelmaier.   

Abstract

A23187-treated platelets secrete dense granule constituents during centrifugation, an artifact that is presented by prior formalin fixation (Holmsen, H., and Setkowsky-Dangelmaier, C. A. (1977) Biochim. Biophys. Acta 497, 46-61). With this improved assay, A23187 induced no secretion in nonaggregating platelets and maximal secretion in aggregating platelets within 3 min. Further incubation gave a slow, submaximal secretion in nonaggregating cells. Acetylsalicylate abolished secretion in both systems. EDTA, but not ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid, strongly enhanced secretion in nonaggregating platelets suspended in Mg2+-containing, Ca2+-free Tyrode's solution. Without added Mg2+, A23187 gave maximal secretion in nonaggregating platelets which was abolished by added Mg2+. Preincubation of A23187 and MgCl2 gave inhibition patterns which clearly suggested that formation of Mg.A23187 species was the cause of inhibition. Ca2+, but not Sr2+, inhibited A23187-induced secretion in the same manner as Mg2+. These findings suggest that the platelet plasma membrane has no or very little permeability for Ca2+ . and Mg2+ . A23187 species. In the physiological suspending medium, Ca2+-free Tyrode's solution, A23187-induced platelet secretion is markedly enhanced by close cell contact (aggregation) and has an absolute requirement for production of prostaglandins and/or thromboxanes. Therefore, the widely held view that secretion is directly triggered by A23187-induced increase in the cytoplasmic Ca2+ concentration is not applicable to platelets.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6793580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Comparative studies on the energetics of platelet responses induced by different agonists.

Authors:  A J Verhoeven; M E Mommersteeg; J W Akkerman
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

2.  Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.

Authors:  J A Ware; P C Johnson; M Smith; E W Salzman
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

3.  Effect of synthetic phospholipids on platelet aggregation and serotonin release.

Authors:  U Söling; H Eibl; G A Nagel; C Unger
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

4.  Differential effects of chlorpromazine on secretion, protein phosphorylation and phosphoinositide metabolism in stimulated platelets.

Authors:  A Opstvedt; S Rongved; N Aarsaether; J R Lillehaug; H Holmsen
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

5.  Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.

Authors:  B H Chao; J A Jakubowski; B Savage; E P Chow; U M Marzec; L A Harker; J M Maraganore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Primary dysfunction in aggregation and secretion of SHRSP platelets: not secondary to the circulation of "exhausted" platelets.

Authors:  K Umegaki; K Nakamura; T Tomita
Journal:  Blut       Date:  1986-01

7.  Prostacyclin inhibits platelet aggregation induced by phorbol ester or Ca2+ ionophore at steps distal to activation of protein kinase C and Ca2+-dependent protein kinases.

Authors:  W Siess; E G Lapetina
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

8.  Effects of cadmium on human platelet reactions.

Authors:  L Pezzi; W Y Cheung
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.